Skip to main content
. 2016 Nov 7;28(4):1306–1313. doi: 10.1681/ASN.2016060640

Table 1.

Baseline characteristics

Baseline Characteristics All Patients, n=34 Control, n=17 Rituximab, n=17 P Value
Age, yr 40 (21–63) 33 (21–59) 43 (29–63) 0.04
Sex, women, men 9, 25 2, 15 7, 10 0.12
Weight, kg 89.7 (57–120) 92.3 (57–119) 85.1 (61–120) 0.46
Race 0.07
 White 24 15 9 0.07
 Black 1 0 1 0.07
 Asian/Pacific Islanders 6 2 4 0.07
 Hispanic/Latino 3 0 3 0.07
Systolic BP 121 (102–147) 118 (102–147) 124 (107–144) 0.17
Diastolic BP 78 (56–106) 78 (56–106) 81 (59–94) 0.24
Creatinine, mg/dl 1.4 (0.8–2.4) 1.3 (0.8–2.4) 1.7 (0.8–2.3) 0.07
eGFR 49 (30–122) 61 (32–122) 40 (30–78) 0.02
24-h Proteinuria, g 2.1 (0.6–5.3) 1.7 (0.6–4.0) 2.6 (0.9–5.3) 0.09
Oxford pathology score, %
 M0/M1 3/97 6/94 0/100 0.30
 E0/E1 68/32 76/24 59/41 0.30
 S0/S1 15/85 12/88 18/82 0.60
 T0/T1/T2 56/41/3 53/47/0 65/29/6 0.30

Data presented as median and range.